| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.072 | 0.1 |